Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Bioinformatics (Oxford, England)
|
December 20, 2000
Bioinformatics in Australia
T Littlejohn
Hawaii Medical Journal
|
December 1, 1996
An attitudinal survey of euthanasia in Windward Oahu. A cross-sectional pilot study of four age groups
T Littlejohn, J Burrows-Johnson
BMJ Nutrition, Prevention & Health
|
January 30, 2025
Nutritional deficiencies and associated pathologies present unique challenges of diagnosing paediatric inflammatory bowel disease in sub-Saharan Africa
Paula T Littlejohn, Taiba Jibril Afaa
Nature Microbiology
|
July 17, 2023
Ethical gut microbiota research in Africa
Paula T Littlejohn, Janiece S Glover
Proceedings. International Conference on Intelligent Systems for Molecular Biology
|
January 1, 1997
Better cutters for protein mass fingerprinting: preliminary findings
M J Wise, T Littlejohn, I Humphery-Smith
Human Mutation
|
September 30, 1999
An online locus-specific mutation database for familial hypertrophic cardiomyopathy
D C Fung, B Yu, T Littlejohn, et al.
American Journal of Hypertension
|
June 2, 1998
Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators
K Kassler-Taub, T Littlejohn, W Elliott, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 1, 1996
Brompheniramine, terfenadine, and placebo in allergic rhinitis
G L Klein, T Littlejohn, E A Lockhart, et al.
The Canadian Journal of Cardiology
|
October 6, 2000
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring
T Littlejohn, W Mroczek, T Marbury, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies
T Littlejohn, R Saini, K Kassler-Taub, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Bioinformatics (Oxford, England)
|
December 20, 2000
Bioinformatics in Australia
T Littlejohn
Hawaii Medical Journal
|
December 1, 1996
An attitudinal survey of euthanasia in Windward Oahu. A cross-sectional pilot study of four age groups
T Littlejohn, J Burrows-Johnson
BMJ Nutrition, Prevention & Health
|
January 30, 2025
Nutritional deficiencies and associated pathologies present unique challenges of diagnosing paediatric inflammatory bowel disease in sub-Saharan Africa
Paula T Littlejohn, Taiba Jibril Afaa
Nature Microbiology
|
July 17, 2023
Ethical gut microbiota research in Africa
Paula T Littlejohn, Janiece S Glover
Proceedings. International Conference on Intelligent Systems for Molecular Biology
|
January 1, 1997
Better cutters for protein mass fingerprinting: preliminary findings
M J Wise, T Littlejohn, I Humphery-Smith
Human Mutation
|
September 30, 1999
An online locus-specific mutation database for familial hypertrophic cardiomyopathy
D C Fung, B Yu, T Littlejohn, et al.
American Journal of Hypertension
|
June 2, 1998
Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators
K Kassler-Taub, T Littlejohn, W Elliott, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 1, 1996
Brompheniramine, terfenadine, and placebo in allergic rhinitis
G L Klein, T Littlejohn, E A Lockhart, et al.
The Canadian Journal of Cardiology
|
October 6, 2000
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring
T Littlejohn, W Mroczek, T Marbury, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies
T Littlejohn, R Saini, K Kassler-Taub, et al.
Page
of 4